UrgoK2^®

INDICATIONS

• Treatment of venous leg ulcers
• Reduction of associated chronic venous oedema (patients with an ABPI >0.8)
• Treatment of lymphoedema

CONTRAINDICATIONS

• Arterial conditions (aterial of predominantly arterial ulcers; known or suspected arterial disease).
• Ankle Brachial Pressure Index (ABPI) < 0.8.
• Patients suffering form diabetic microangiopathy, ischaemic phlebitis, septic thrombosis.
• Ulceration due to infection.
• Allergy to any of the components

PRECAUTIONS

• Check that the ABPI > 0.8 using Doppler ultrasound before prescribing the bandage system.
• In the event of diabetes, heart failure or advanced microvascular disease, use the compression system with close medical monitoring and after appropriate treatment.
• In case of peri-ulcer infectious dermatosis, treat infection before starting a treatment with the compression system.
• In case of an ulcer from rare origin (vasculitis, haemopathy, pyoderma, gangrenosum,…) the compression system should only be used following specialist referral.
• The efficacy of UrgoK2 (or UrgoK2 Lite) has been tested and validated for the application of KTECH (or KTECH LITE) and KPRESS together.
• The PresSure System has been designed to aid application of the bandages; it is important to follow the instructions carefully to achieve the recommended therapeutic pressure.
• If any difficulty arises, consult your doctor or clinician immediately.

DIRECTIONS FOR USE

PRODUCT OPTIONS

Supplied in kits containing 2 components: 1 KTech + 1 KPress

CLINICAL EVIDENCE

1. Junger M, et al. Comparison of interface pressures of three compression bandaging systems used on healthy volunteers. J Wound Care. 2009;18(11): 474,476-80.